Biogen (BIIB) Change in Acquisitions & Divestments (2016 - 2025)
Historic Change in Acquisitions & Divestments for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$33.6 million.
- Biogen's Change in Acquisitions & Divestments rose 6525.34% to -$33.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $23.0 million, marking a year-over-year change of. This contributed to the annual value of $23.0 million for FY2025, which is N/A changed from last year.
- As of Q4 2025, Biogen's Change in Acquisitions & Divestments stood at -$33.6 million, which was up 6525.34% from $56.6 million recorded in Q3 2025.
- In the past 5 years, Biogen's Change in Acquisitions & Divestments ranged from a high of $5.7 billion in Q3 2023 and a low of -$96.7 million during Q4 2024
- For the 5-year period, Biogen's Change in Acquisitions & Divestments averaged around $851.8 million, with its median value being $566.3 million (2022).
- In the last 5 years, Biogen's Change in Acquisitions & Divestments soared by 24679.89% in 2023 and then plummeted by 9985.1% in 2024.
- Over the past 5 years, Biogen's Change in Acquisitions & Divestments (Quarter) stood at $1.4 billion in 2021, then plummeted by 58.88% to $566.3 million in 2022, then surged by 906.29% to $5.7 billion in 2023, then crashed by 101.7% to -$96.7 million in 2024, then surged by 65.25% to -$33.6 million in 2025.
- Its Change in Acquisitions & Divestments was -$33.6 million in Q4 2025, compared to $56.6 million in Q3 2025 and -$96.7 million in Q4 2024.